Catalyst Wire Dossier Catalyst Wire Dossier

Norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets

Norethindrone acetate and ethinyl estradiol · Xiromed, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets, covering 2023-06-21 to 2023-06-21. Get the full timeline:

Most recent: FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Xiromed, LLC)

See pricing